Single-dose Effectiveness of Mpox Vaccine in Quebec, Canada: Test-negative Design With and Without Adjustment for Self-reported Exposure Risk.

Saved in:
Bibliographic Details
Title: Single-dose Effectiveness of Mpox Vaccine in Quebec, Canada: Test-negative Design With and Without Adjustment for Self-reported Exposure Risk.
Authors: Brousseau N; Biological Risks Department, Institut national de santé publique du Québec, Quebec, QC, Canada.; Axe Maladies infectieuses et immunitaires, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Quebec, QC, Canada.; Social and Preventive Medicine Department, Faculty of Medicine, Laval University, Quebec, QC, Canada., Carazo S; Biological Risks Department, Institut national de santé publique du Québec, Quebec, QC, Canada.; Social and Preventive Medicine Department, Faculty of Medicine, Laval University, Quebec, QC, Canada., Febriani Y; Axe Maladies infectieuses et immunitaires, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Quebec, QC, Canada., Padet L; Biological Risks Department, Institut national de santé publique du Québec, Quebec, QC, Canada., Hegg-Deloye S; Axe Maladies infectieuses et immunitaires, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Quebec, QC, Canada., Cadieux G; Direction régionale de santé publique de Montréal, Centre intégré universitaire de santé et de services sociaux du Centre-Sud-de-l'Île-de-Montréal, Montreal, QC, Canada.; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, QC, Canada., Bergeron G; Direction régionale de santé publique de Montréal, Centre intégré universitaire de santé et de services sociaux du Centre-Sud-de-l'Île-de-Montréal, Montreal, QC, Canada., Fafard J; Laboratoire de santé publique du Québec, Institut national de santé publique du Québec, Québec, QC, Canada., Charest H; Laboratoire de santé publique du Québec, Institut national de santé publique du Québec, Québec, QC, Canada.; Faculty of Medicine, University of Montreal, Montreal, QC, Canada., Lambert G; Direction régionale de santé publique de Montréal, Centre intégré universitaire de santé et de services sociaux du Centre-Sud-de-l'Île-de-Montréal, Montreal, QC, Canada., Talbot D; Social and Preventive Medicine Department, Faculty of Medicine, Laval University, Quebec, QC, Canada., Longtin J; Axe Maladies infectieuses et immunitaires, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Quebec, QC, Canada., Dumont-Blais A; Mpox Awareness Team, RÉZO Community Organization, Montreal, QC  Canada., Bastien S; Mpox Awareness Team, RÉZO Community Organization, Montreal, QC  Canada., Dalpé V; Biological Risks Department, Institut national de santé publique du Québec, Quebec, QC, Canada., Minot PH; Biological Risks Department, Institut national de santé publique du Québec, Quebec, QC, Canada., De Serres G; Biological Risks Department, Institut national de santé publique du Québec, Quebec, QC, Canada.; Axe Maladies infectieuses et immunitaires, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Quebec, QC, Canada., Skowronski DM; Immunization Programs and Vaccine Preventable Diseases Service, BC Centre for Disease Control, Vancouver, British Columbia, Canada.; School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Feb 17; Vol. 78 (2), pp. 461-469.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1537-6591
DOI:10.1093/cid/ciad584